Amar Mohee is a consultant urological surgeon, working at the Manchester University NHS Foundation Trust (MFT). Amar did his medical training at the University of Manchester, before moving across the Pennines to undertake research in urology at the University of Leeds. He was awarded a doctorate in medicine for his thesis titled ‘Infection in urological practice: bacteraemia and infective endocarditis’. Following his research, he moved back to Manchester to complete his urological training. Before starting as a consultant surgeon at the Manchester Royal Infirmary, Amar moved to Paris for a fellowship in robotic surgery and uro-oncology at the prestigious Henri Mondor Hospital, APHP, France.
He is currently the lead in urological cancer at the Manchester Royal Infirmary. He has set up the robotic programme for bladder cancer management at the MFT.
Professor Choudhury is Chair and Honorary Consultant in Clinical Oncology. She specialises in urology and sarcoma and has a strong interest in translational research. She is clinical lead for advanced radiotherapy including the MRLinac project and is co-Group Leader of The Translational Radiobiology Group within the Division of Cancer Sciences. She currently undertakes research which aims to optimise and personalise radiotherapy using new techniques or imaging technology to deliver high doses of radiotherapy while minimising side effects and predictive biomarkers to determine which patients benefit from different treatments.
Professor John Kelly is a professor of Uro-oncology at University College London and Honorary Consultant Urologist at University College London Hospital. He was head of the Department of Urology at UCLH to 2020 and Director for robotic surgery at the Chitra Sethia Centre. He leads a genomics research group investigating epigenetic and genomic alterations in bladder cancer which can be exploited to predict outcomes and detect disease.
Mr Hugh Mostafid is a consultant urologist at the Royal Surrey County Hospital in Guildford and Honorary Senior Lecturer at the University of Surrey. His main research interests are the diagnosis and treatment of bladder cancer. He is also a member of the European Association of Urology Bladder Cancer guidelines panel.